Randomized Trial of Technology-assisted Self-monitoring of Blood Glucose by Low-income Seniors: Improved Glycemic Control in Type 2 Diabetes Mellitus
Overview
Authors
Affiliations
Self-monitoring of blood glucose (SMBG) has been recommended for people with type 2 diabetes mellitus. This trial tested an automated self-management monitor (ASMM) that reminds patients to perform SMBG, provides feedback on results of SMBG, and action tips for improved self-management. This delayed-start trial randomized participants to using the ASMM immediately (IG), or following a delay of 6 months (DG). Glycated hemoglobin (HgbA1c) level and survey data was collected at home visits every 3 months. 44 diabetic men and women, mean age 70, completed the 12-month trial. Baseline HgbA1c was 8.1 % ± 1.0, dropping to 7.3 ± 1.0 by 9 months, with a 3-month lag in the DG (F = 3.56, p = 0.004). Decrease in HgbA1c was significantly correlated to increased frequency of SMBG, R = 0.588, p < 0.01. Providing older diabetics with objective immediate contingent feedback resulted in more frequent SMBG that correlated with better glycemic control. This type of technology may provide real-time feedback not only to patient users, but to the health care system, allowing better integration of provider recommendations with patient-centered action.
Fotteler M, Muhlbauer V, Brefka S, Mayer S, Kohn B, Holl F JMIR Aging. 2022; 5(2):e31916.
PMID: 35377322 PMC: 9016506. DOI: 10.2196/31916.
Zacher M, Wang J, Short S J Gerontol B Psychol Sci Soc Sci. 2021; 77(2):378-388.
PMID: 33528509 PMC: 8824611. DOI: 10.1093/geronb/gbab022.
Treatment adherence and illness self-management: introduction to the special issue.
Howren M, Gonzalez J J Behav Med. 2016; 39(6):931-934.
PMID: 27766482 DOI: 10.1007/s10865-016-9804-0.
Leventhal H, Phillips L, Burns E J Behav Med. 2016; 39(6):935-946.
PMID: 27515801 DOI: 10.1007/s10865-016-9782-2.